A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2011
10/05/2011	CN102204900A Application of sodium oxamate in preparing drugs for radiotherapy sensitization
10/05/2011	CN102204892A Gingko flavanone aglycone dropping pills and preparation method thereof
10/05/2011	CN102204889A Degarelix acetate lyophilized powder injection and preparation method thereof
10/05/2011	CN102204881A Gel sustained-release injection containing camptothecin or derivatives thereof, and preparation method thereof
10/05/2011	CN101979013B Traditional Chinese medicine for treating leukemia
10/05/2011	CN101972454B Medicament for treating lymphoma
10/05/2011	CN101926809B Pharmaceutical preparation and preparation method thereof
10/05/2011	CN101829210B Method for preparing apple polyphenol
10/05/2011	CN101732373B Resina toxicodendri extract and anticancer medicine using same as effective component
10/05/2011	CN101716204B Anticancer analgesic preparation and preparation method thereof
10/05/2011	CN101711855B Traditional Chinese medicine preparation for treating gastric cancer and preparation method
10/05/2011	CN101711848B Chinese medicinal composition capable of adjunctively treating tumour
10/05/2011	CN101705227B SiRNA for inhibiting human AP-2alpha gene expression and anti-cervical cancer application thereof
10/05/2011	CN101658516B Taxol medicinal compositions and preparation method thereof
10/05/2011	CN101624388B Method for extracting proanthocyanidin from peanut coats
10/05/2011	CN101612357B Chinese traditional medicine composition for treating tumor and preparing method thereof
10/05/2011	CN101548950B Tripterine nanometer lipid injection and method for preparing same
10/05/2011	CN101492339B Process and apparatus for the extraction separation of beta-elemene, and process for producing stuffing
10/05/2011	CN101433693B Effective component of turmeric rhizome and preparation method and use thereof
10/05/2011	CN101428129B Effective component of turmeric rhizome, preparation method and uses thereof
10/05/2011	CN101428120B Effective component of phragmites communis trin, preparation method and use thereof
10/05/2011	CN101407556B Preparation of Cordyceps sinensis polysaccharide injection and use in cancer treatment
10/05/2011	CN101391006B Medicine composition for treating tumor and preparation method thereof
10/05/2011	CN101347566B Effective component of airpotato yam as well as preparation method and use thereof
10/05/2011	CN101347565B Effective component of Japanese yam as well as preparation method and use thereof
10/05/2011	CN101347501B Effective component of Rabdosia amethystoides and preparation and use thereof
10/05/2011	CN101347497B Effective component of vietnamese sophora root and preparation and use thereof
10/05/2011	CN101347496B Effective component of Spatholobus stem and preparation and use thereof
10/05/2011	CN101347480B Effective component of inula flower and preparation and use thereof
10/05/2011	CN101347479B Effective component of acanthopanax and preparation and use thereof
10/05/2011	CN101347467B Effective component of common camptotheca fruit and preparation as well as use thereof
10/05/2011	CN101336924B New use of cardiac glycoside in calotropis gigantea for anti-tumour
10/05/2011	CN101255146B 5/7/6 type 13(15) site epoxy taxane diterpenoid, medicament combination and uses thereof
10/05/2011	CN101225031B Disubstituted allyl benzene derivatives as well as preparation and uses thereof
10/05/2011	CN101199859B Inhibition lung cancer transfer and lung transfer tumor gene medicament
10/05/2011	CN101134046B Application of TLR4 and TLR9 agonist compound in the restraint of tumour metastasis
10/05/2011	CN101132694B Medical device with coating for capturing genetically-altered cells and methods of using same
10/04/2011	US8030487 2-amino—5-substituted pyrimidine inhibitors
10/04/2011	US8030462 Immunotherapy; induce immunology response
10/04/2011	US8030348 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
10/04/2011	US8030336 Nicotinamide-based kinase inhibitors
10/04/2011	US8030317 MAPK/ERK kinase inhibitors
10/04/2011	US8030305 Triazolopyridazines as kinase modulators
10/04/2011	US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
10/04/2011	US8030283 Stabilization of amrubicin hydrochloride
10/04/2011	US8030280 Melanoma antigens and their use in diagnostic and therapeutic methods
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	US8030278 Methods, compositions and articles of manufacture for contributing to the treatment of cancers
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	US8029833 Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
10/04/2011	US8029808 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes
10/04/2011	US8029787 Method of diagnosing, monitoring, staging, imaging and treating various cancers
10/04/2011	US8029784 Method for the diagnosis and prognosis of malignant diseases
10/04/2011	US8029778 Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3
10/04/2011	US8029768 pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
10/04/2011	CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/04/2011	CA2494536C A 12-membered ring macrolide active substance
10/04/2011	CA2480308C Antisense iap nucleobase oligomers and uses thereof
10/04/2011	CA2478099C Inhibitors
10/04/2011	CA2431199C Immunotherapeutic kit for the treatment of tumors
10/04/2011	CA2381123C Actinium-225 complexes and conjugates for radioimmunotherapy
10/04/2011	CA2371839C Hydroxymatairesinol in cancer prevention
10/04/2011	CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
10/04/2011	CA2224075C Vectors for the diagnosis and treatment of solid tumors including melanoma
09/2011
09/29/2011	WO2011119988A1 Methods of treatment of hepatocellular carcinoma
09/29/2011	WO2011119979A2 Antibodies to muc16 and methods of use thereof
09/29/2011	WO2011119925A2 Synthetic herpes simplex viruses for treatment of cancers
09/29/2011	WO2011119759A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
09/29/2011	WO2011119661A1 Anti-lrp6 antibodies
09/29/2011	WO2011119628A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
09/29/2011	WO2011119625A1 D. innoxia withanolides with specific anti-cancer activities
09/29/2011	WO2011119553A1 Materials and methods related to modulation of mismatch repair and genomic stability by mir-155
09/29/2011	WO2011119549A1 Trioxacarcins and uses thereof
09/29/2011	WO2011119345A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/29/2011	WO2011119126A1 Use of oxalic acid in the production of a therapeutic preparation with anti-tumour activity in relation to malignant cells, a therapeutic preparation based thereon and a method of treatment
09/29/2011	WO2011119125A1 Use of lithium oxalate in production of a therapeutic preparation with anti-tumour activity in relation to malignant cells, a therapeutic preparation based thereon and a method of treatment
09/29/2011	WO2011118994A2 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof
09/29/2011	WO2011118981A2 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer
09/29/2011	WO2011118929A2 Novel crystal forms of epirubicin hydrochloride
09/29/2011	WO2011118819A1 Gene therapy for hematopoietic tumor by proliferation-regulated virus vector carrying survivin promoter
09/29/2011	WO2011118778A1 Cell proliferation suppression agent and method for screening same
09/29/2011	WO2011118759A1 Benzanilide derivative
09/29/2011	WO2011117882A1 Pyrrolo[2,l-c][l,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof
09/29/2011	WO2011117830A1 Derivatives of phenazine useful to treat cancer
09/29/2011	WO2011117668A1 Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
09/29/2011	WO2011117449A1 Enantiomers of benzoheteroepine derivatives and use thereof as anti-carcinogenic agents
09/29/2011	WO2011117429A1 Cannabinoid quinone derivatives
09/29/2011	WO2011117382A1 Pyridyltriazoles
09/29/2011	WO2011117381A1 B-raf kinase inhibitors
09/29/2011	WO2011117353A1 Bivalent antisense oligonucleotides
09/29/2011	WO2011117330A1 Bispecific antibodies
09/29/2011	WO2011117328A1 Method and compositions to induce apoptosis of tumoral cells expressing shh
09/29/2011	WO2011117163A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators
09/29/2011	WO2011116954A2 Prophylaxis of colorectal and gastrointestinal cancer
09/29/2011	WO2011116951A1 Pharmaceutically active disubstituted triazine derivatives
09/29/2011	WO2011116867A1 Benzonaphthyridinamines as autotaxin inhibitors
09/29/2011	WO2011076095A8 Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
09/29/2011	WO2011056957A3 Enzyme inhibiting compounds

1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 2211